21594 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins; Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin
MULTIVALENT IMMUNOCONJUGATES FOR TARGETED RADIOISOTOPE THERAPY
#2Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer
#3HYBRID IMMUNOGLOBULINS WITH MOVING PARTS
#4COMBINATION THERAPY FOR CANCER
#5Hybrid immunoglobulins with moving parts
#6Immuno imaging agent for use with antibody-drug conjugate therapy
#7Pharmacokinetic determination of intravitreal agents
#8Biokinetics of fast-clearing polypeptides
#9Combination of an anti ED-B fibronectin domain antibody and gemcitabine
#10Cancerous disease modifying antibodies
#11Hybrid immunoglobulins with moving parts